The Efficacy of Clofibrate (CPIB) in Familial Hyperlipoproteinemias
This presentation will describe the use of diet, Clofibrate, and one other drug on the treatment of different kinds of familial hyperlipidemia. The latter disorders were classified as different types of hyperlipoproteinemia (1). The use of such grouping of patients has many distinct advantages. Probably these are greatest in pharmacologic or dietary experiments and the extension of the results to practical management of affected patients. This has been demonstrated in the systematic trial of Clofibrate (CPIB, Atromid-S®) on each of the five major types of familial hyperlipoproteinemia. The companion effects of drug and diet have also been carefully evaluated. A fuller description of each type of hyperlipoproteinemia is presented elsewhere in this symposium (2).
KeywordsPlasma Cholesterol Plasma Triglyceride Creatine Phosphokinase Diet Therapy Peripheral Blood Flow
Unable to display preview. Download preview PDF.
- 2.Fredrickson, D.S., Levy, R.I., Kwiterovich, P.O., Jr., and Jover, A. Milan Symposium (1968) (Plenum Publishing Corporation, New York).Google Scholar
- 3.Levy, R.I. and Fredrickson, D.S. Amer. J. Cardiol., in press (1968).Google Scholar
- 4.Levy, R.I., Quarfordt, S.H., Sloan, H.R., Brown, W.V. and Fredrickson, D.S. (abstract) Circulation 36: 171 (1967).Google Scholar
- 5.Levy, R.I. and Fredrickson, D.S. In preparation.Google Scholar
- 6.Technicon Instruments, Total Cholesterol Procedure N-24a in Autoanalyzer Manual, Chauncey, New York (1964).Google Scholar
- 7.Kessler, G. and Lederer, H. In L.T. Skess, Jr. (Ed.), Automation in Analy. Chem., Medical Inc., New York (1966).Google Scholar
- 8.Lees, R.S. and Hatch, F.T. J. Lab. Clin. Med. 61:518 (1963).Google Scholar
- 9.Langer, T. and Levy, R.I. New England J. Med., in press (1968).Google Scholar
- 10.Zelis, R., Mason, D.T., Braunwald, E. and Levy, R.I. (abstract) Circulation, in press (1968).Google Scholar